Get Premium to unlock powerful stock data

Top 5 1st Quarter Trades of Eagle Health Investments LP

Author's Avatar
insider
May 12, 2022
Article's Main Image

Eagle Health Investments LP recently filed their 13F report for the first quarter of 2022, which ended on 2022-03-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

67 HOLLY HILL LANE GREENWICH, CT 06830

As of the latest 13F report, the guru’s equity portfolio contained 28 stocks valued at a total of $406,000,000. The top holdings were HUM(8.35%), SGEN(8.18%), and AZN(7.28%).

According to GuruFocus data, these were Eagle Health Investments LP’s top five trades of the quarter.

Seagen Inc


During the quarter, Eagle Health Investments LP bought 150,002 shares of NAS:SGEN for a total holding of 230,502. The trade had a 5.32% impact on the equity portfolio. During the quarter, the stock traded for an average price of $135.09.

On 05/12/2022, Seagen Inc traded for a price of $124.06 per share and a market cap of $26,094,966,000. The stock has returned -14.11% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, Seagen Inc has a price-book ratio of 8.72, a EV-to-Ebitda ratio of -40.06 and a price-sales ratio of 15.53.

The price-to-GF Value ratio is 0.81, earning the stock a GF Value rank of 10.

Natera Inc


During the quarter, Eagle Health Investments LP bought 235,800 shares of NAS:NTRA for a total holding of 447,494. The trade had a 2.37% impact on the equity portfolio. During the quarter, the stock traded for an average price of $60.26.

On 05/12/2022, Natera Inc traded for a price of $28.505 per share and a market cap of $3,083,308,000. The stock has returned -68.83% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, Natera Inc has a price-book ratio of 5.80, a EV-to-Ebitda ratio of -5.36 and a price-sales ratio of 4.56.

The price-to-GF Value ratio is 0.36, earning the stock a GF Value rank of 4.

AstraZeneca PLC


Eagle Health Investments LP reduced their investment in NAS:AZN by 166,000 shares. The trade had a 2.36% impact on the equity portfolio. During the quarter, the stock traded for an average price of $59.94.

On 05/12/2022, AstraZeneca PLC traded for a price of $61.25 per share and a market cap of $187,739,714,000. The stock has returned 16.20% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, AstraZeneca PLC has a price-book ratio of 5.53, a EV-to-Ebitda ratio of 33.27 and a price-sales ratio of 4.77.

The price-to-GF Value ratio is 0.89, earning the stock a GF Value rank of 6.

American Well Corp


During the quarter, Eagle Health Investments LP bought 1,563,100 shares of NYSE:AMWL for a total holding of 3,811,008. The trade had a 1.62% impact on the equity portfolio. During the quarter, the stock traded for an average price of $4.22.

On 05/12/2022, American Well Corp traded for a price of $2.855 per share and a market cap of $894,733,000. The stock has returned -79.46% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, American Well Corp has a price-book ratio of 0.71, a EV-to-Ebitda ratio of -0.01 and a price-sales ratio of 3.37.

Cano Health Inc


During the quarter, Eagle Health Investments LP bought 1,007,333 shares of NYSE:CANO for a total holding of 2,955,112. The trade had a 1.57% impact on the equity portfolio. During the quarter, the stock traded for an average price of $6.31.

On 05/12/2022, Cano Health Inc traded for a price of $4.22 per share and a market cap of $923,040,000. The stock has returned 0.00% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, Cano Health Inc has a price-book ratio of 2.51, a EV-to-Ebitda ratio of -118.45 and a price-sales ratio of 0.47.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus